Danaher acquires Masimo for nearly $10B to enhance its diagnostics and patient monitoring portfolio. The deal is expected to be accretive to earnings, with significant synergy targets.

The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale ...

Danaher shares are under pressure Wednesday as the Club holding's fourth-quarter earnings results came in mixed and guidance disappointed. The company long known for its operational excellence is ...

Philip Morris rides pricing power and smoke-free growth, while Lockheed Martin and Danaher navigate industry tailwinds and operational hurdles.

The latest beat-and-raise quarter from Danaher is reviving Wall Street's hopes for the stock. Can it last? Danaher, a supplier of tools and equipment to drugmakers and hospitals, had been known for ...

Danaher faced a disappointing 2024, despite beating Q3 expectations, due to unaltered full-year guidance and a significant asset writedown. The company executed a $4.5 billion share buyback, with an ...

Danaher (NYSE:DHR) is preparing to release its quarterly earnings on Wednesday, 2026-01-28. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect ...

April 22 (Reuters) - Danaher (DHR.N), opens new tab beat Wall Street estimates for first-quarter profit on Tuesday, on the back of better-than-expected demand for its respiratory testing kits, and ...

Andvari Associates, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter the fund returned 7.2% net of fees ...

Partnership seeks to improve patient outcomes and experience through novel digital and diagnostic solutions. Investment aligns with Danaher's mission to accelerate the transition to precision medicine ...

During the last three months, 8 analysts shared their evaluations of Danaher (NYSE:DHR), revealing diverse outlooks from bullish to bearish. The table below provides a concise overview of recent ...

WASHINGTON, July 22, 2025 /PRNewswire/ -- Danaher Corporation (DHR), a leading global life sciences and diagnostics innovator, today announced that Matthew Gugino, currently Group Chief Financial ...